Prostate News Archive
27-Sep-2007
Prostate cancer drug promising (The News Journal)
The results of an experimental AstraZeneca drug for treating prostate cancer were promising in a clinical trial, researchers said Tuesday at an international cancer conference in Barcelona, Spain. Prostate cancer prevention: past, present, and future (News-Medical-Net)
Recent investigations of medications, diet and the molecular understanding of prostate cancer are defining potential prevention strategies for the disease, and herald a new stage in the management of this cancer, according to a new review. New AstraZeneca compound shows promoise for hormone resistant prostate cancer patients with bone metastases (News-Medical-Net)
New Phase II data suggests that ZD4054, a novel compound in development for the treatment of men with Hormone Resistant prostate Cancer (HRPC), could offer a promising improvement in overall survival in men with metastatic HRPC who were asymptomatic or mildly symptomatic for pain.
Back to Prostate News Archive